Objectives: To present the recommendations and supporting literature for RBC transfusions in critically ill children with bleeding developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Design: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children. Methods: The panel of 38 experts developed evidence-based and, when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The respiratory subgroup included six experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method. Results: Transfusion and Anemia Expertise Initiative experts developed seven recommendations focused on children with acute respiratory failure. All recommendations reached agreement (> 80%). Transfusion of RBCs in children with respiratory failure with an hemoglobin level less than 5 g/dL was strongly recommended. It was strongly recommended that RBCs not be systematically administered to children with respiratory failure who are hemodynamically stable and who have a hemoglobin level greater than or equal to 7 g/dL. Experts could not make a recommendation for children with hemodynamic instability, with severe hypoxemia and/or with an hemoglobin level between 5 and 7 g/dL. Specific A nemia is very common in PICUs, with 74% of critically ill children with a PICU stay of more than 2 days experiencing a hemoglobin level below normal at PICU admission or during the PICU stay. As a consequence of anemia, up to 49% of these critically ill children receive at least one RBC transfusion during their PICU stay (1) .
Oxygen delivery (Do 2 ) is a fundamental concept for the management of critically ill patients. The final goal of resuscitation maneuvers is to maintain or restore adequate Do 2 and oxygen consumption (2) . Do 2 is defined as the product of cardiac output (CO) and arterial content of oxygen (Cao 2 ) (Do 2 = CO × Cao 2 ) (3). The Cao 2 depends mainly on the hemoglobin concentration and its saturation in oxygen: children suffering from anemia and respiratory distress are thus at increased risk of altered Do 2 .
It has been shown that PICU physicians frequently use RBC transfusions in order to improve Do 2 (4). However, respiratory adverse events can be caused by RBC transfusions, including transfusion-related acute lung injury (ALI), transfusion-associated circulatory overload, and transfusionassociated respiratory dysfunction (5), all of which may compromise diffusion of oxygen from the alveoli to the blood. Furthermore, storage lesions (i.e., modifications of RBCs during storage) can reduce the ability of the transfused RBCs to bring oxygen to the cells. For example, stored RBCs may show a reduced membrane deformability compromising their passage in the microcirculation (6), or nitric oxide (NO) signaling may be compromised by storage which may lead to transfusion-induced acute microvascular dysregulation (7, 8) . Thus, although it is indisputable that RBC transfusion increases blood oxygen content, it is not clear that stored RBCs are as helpful as expected to improve Do 2 to the cells. It is therefore of high importance to define appropriate transfusion strategies for critically ill children, and it is highly relevant to pay particular attention to children with acute respiratory distress who are at high risk for inadequate Do 2 .
METHODS
The details of the methodology are described elsewhere in this supplement of Pediatric Critical Care Medicine (9) . Briefly, we searched PubMed, EMBASE, and Cochrane Library from 1980 to December 2015, with an update in May 2017, using a combination of medical subject heading terms and text words to define concepts of RBC transfusion and acute respiratory failure in children. We searched references from identified articles for additional publications. Two authors reviewed all citations independently. We used a standardized data extraction form to construct evidence tables and graded the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. A panel of 38 experts from 29 academic institutions in eight countries met over the course of 2 years to develop evidence-based and, when evidence was lacking, expertbased recommendations for RBC transfusion in critically ill children. Six experts coordinated the acute respiratory failure subgroup. Recommendations developed and supporting literature were reviewed and scored by all panel members, using the Research and Development/UCLA Appropriateness Method. All recommendations reached agreement (> 80%). Final recommendations for RBC transfusion in critically ill children with acute respiratory failure were divided into two categories: clinical recommendations and research recommendations.
Our recommendations use the criteria of severe hypoxemia, as defined in the Transfusion Strategies in Pediatric Intensive Care Units (TRIPICU) study (10) . In TRIPICU, hypoxemia was defined as a pulsed oxygen saturation (Spo 2 ) less than or equal to 90% on pulse oximeter with an Fio 2 greater than or equal to 60%. We used these criteria to define severe hypoxemia for our recommendations, considering that the TRIPICU study is currently the most solid available evidence to guide RBC transfusions in critically ill children. However, recently, the Pediatric Acute Lung Injury Consensus Conference (PALICC) Group defined severe pediatric acute respiratory distress syndrome (PARDS) based on an oxygenation index greater than or equal to 16 or, if Pao 2 not available, on an oxygen saturation index greater than or equal to 12.3 (11) . We acknowledge that these criteria (rather than the TRIPICU criteria) should probably be used to define severe hypoxemia in future studies on RBC transfusion strategies in critically ill children with respiratory failure.
RESULTS
Using the search strategy described above, we retrieved 5,428 abstracts. Eighty-three articles were retained for the full-text evaluation, among which 25 articles were selected and used in the final process to generate recommendations, good practice statements, and research questions and are presented in the Supplemental Rationale. In children, respiratory distress has been shown to be associated with increased mortality in the context of severe anemia. In a descriptive study of 1,866 children admitted to a Kenyan hospital with a primary diagnosis of anemia, the mortality reported by Marsh et al (12) was 1.3% if severe anemia (hemoglobin < 5 g/dL) was present without respiratory distress and increased to 22.7% if severe respiratory distress was present. English et al (13) reported that among 1,516 children with malaria and severe anemia (hemoglobin < 5 g/dL) hospitalized in Kenya, mortality did not differ between transfused and nontransfused children when considering the entire group (5% vs 7%, respectively) but was significantly reduced in transfused children with respiratory distress (11% vs 25% for nontransfused children with respiratory distress). In 2,433 anemic African children with respiratory distress and a hemoglobin less than 4.7 g/dL, Lackritz et al (14) observed that those who were transfused had a reduced risk of mortality as compared to those not transfused (odds ratio, 0.19; 95% CI, 0.09-0.41); there was no association between receiving a transfusion and mortality among children without respiratory distress regardless of the hemoglobin level at admission. In a subsequent study, Lackritz et al (15) enrolled 303 children with a hemoglobin level less than 5 g/dL; 116 (38%) who did not receive a transfusion mostly because blood products were not available. Each child with severe anemia was matched with the next child hospitalized with a hemoglobin greater than 5 g/dL. Mortality was 19.5% in 303 patients with a hemoglobin greater than 5 g/dL who were not transfused, 21.4% in 187 patients with a hemoglobin less than 5 g/dL who were transfused, and 41.4% in 116 patients with a hemoglobin less than 5 g/dL who were not transfused. These researchers thus confirmed that in severely anemic children (hemoglobin < 5 g/dL), RBC transfusion had the greatest impact on survival when clinical signs of respiratory distress were present; furthermore, they reported that the benefit of transfusion was limited to the first 2 days of hospitalization. In a study involving 241 children admitted to the hospital with severe malaria and metabolic acidosis, Akech et al (16) observed that it was safe to apply the World Health Organization (WHO) guidelines, that is, to transfuse 20 mL/kg of whole blood if the hemoglobin is less than 4 g/dL or if it is less than 5 g/dL and associated with respiratory distress. Indeed, the in-hospital mortality was 7.7% for children with severe symptomatic malaria at admission requiring urgent transfusion according to WHO guidelines and 8.8% for children who did not fulfill the WHO transfusion criteria at the time of admission to hospital but who were transfused later during the course of their admission. Furthermore, the restrictive transfusion strategy suggested by the WHO did not affect hematologic recovery, which was identical for transfused survivors (n = 61, including 46 (76%) with respiratory distress) and nontransfused survivors (n = 97, including 54 (56%) with respiratory distress): the hemoglobin at hospital discharge was 6.4 ± 1.5 versus 6.8 ± 1.6 g/dL, respectively (p = 0.08), and the follow-up hemoglobin (within 22-35 d post admission) was 10.2 ± 1.7 versus 10.0 ± 1.3 g/dL, respectively (p = 0.25).
It must be noted that all these observations were made in patient populations in whom severe anemia arose from various acute, subacute, and chronic illnesses, which might have confounded the beneficial impact of receiving a transfusion. Furthermore, these studies on children with severe anemia were conducted in Africa, which may limit the generalizability of the results to other populations in other countries.
Adult data also show that severe anemia is associated with worse outcomes, especially when the hemoglobin level falls below 5 g/dL (17) (18) (19) . In a retrospective cohort study performed in 1,958 adult patients who underwent surgery and declined blood transfusion for religious reasons, Carson et al (20) found a mortality of 1.3% in patients with preoperative hemoglobin greater than or equal to 12 g/dL versus 33.3% in patients with preoperative hemoglobin less than 6 g/dL. It is interesting to note that among those with a postoperative hemoglobin less than 6 g/dL who died in the hospital, 35.9% had a respiratory failure at the time of death (21) . "GRADE 1C based on upgrading for large treatment effect, and downgrading for imprecision and indirectness-observational studies." 2.2 In critically ill children with respiratory failure who do not have severe acute hypoxemia, a chronic cyanotic condition or hemolytic anemia, and whose hemodynamic status is stable, we recommend not administering a RBC transfusion if the Hb concentration is ≥ 7 g/ dL.
Strong recommendation, Moderate quality pediatric evidence (1B). Voting data (n = 29): 100% agreement, median 8.5, IQR 8-9.
Rationale. The TRIPICU study showed that a restrictive RBC transfusion strategy (i.e., to transfuse when the hemoglobin level is < 7 g/dL) is not inferior to a liberal strategy (i.e., to transfuse when the hemoglobin level is < 9.5 g/dL) in children who are hemodynamically stable (i.e., children whose mean arterial pressure is not < 2 sds below normal mean for age and whose cardiovascular support has not been increased in the last 2 hr) but leads to a significant decrease of exposure to RBC transfusions (10) . Indeed, the 320 children randomized in the restrictive strategy group and the 317 children randomized in the liberal strategy group showed the same outcomes (occurrence of new or progressive multiple organ dysfunction syndrome (NPMODS): 12% in each group, absolute risk reduction 0.4% (95% CI, 0.61-1.49; p = 0.84), but the proportion of nontransfused children was 54% in the restrictive strategy group versus 2% in the liberal strategy group (p < 0.001).
Among the 637 children included in the TRIPICU study, 480 (75.4%) had respiratory dysfunction at the time of admission to PICU. Respiratory dysfunction was defined as the Pediatric Critical Care Medicine www.pccmjournal.org S117 presence of any one of the following criteria: 1) respiratory rate greater than 90 breaths/min (< 1 yr) or greater than 70 breaths/ min (≥ 1 yr), 2) Pao 2 less than 40 torr (5.3 kPa) in absence of cyanotic heart disease, 3) Paco 2 greater than 65 torr (8.7 kPa), 4) Pao 2 /Fio 2 less than 200 in absence of cyanotic heart disease, 5) mechanical ventilation (> 24 hr if postoperative). The incidence of NPMODS in these children was 14.1% in the restrictive group versus 14.2% in the liberal group. "GRADE 1B based on downgrading for imprecision (single high quality randomized controlled trial [RCT])." 2.3 In critically ill children with respiratory failure who have severe hypoxemia, we cannot make a recommendation regarding optimal RBC transfusion strategy.
Consensus panel expertise. Voting data (n = 29): 97% agreement, median 8, IQR 8-9.
Rationale. This recommendation is in accordance with the recent PALICC (11) , in which children with severe hypoxemia were excluded from the recommendation on the safety of a restrictive transfusion strategy (hemoglobin threshold 7 g/dL) in children with PARDS.
Some children included in the TRIPICU study had acute respiratory distress syndrome (ARDS) (n = 48, including 23 children in the restrictive group and 25 children in the liberal group) or ALI (n = 73, including 38 children in the restrictive group and 35 children in the liberal group) at admission to PICU (defined according to the criteria prior to the Berlin criteria, i.e., the 1994 American-European Consensus Conference definition of ARDS [22] ). Among them, 18 of 61 (29.5%) in the restrictive group versus 15 of 60 (25%) in the liberal group developed NPMODS subsequently, with no statistical difference but with a statistical power inferior to 10%. Thus, data from the TRIPICU study indicate that a restrictive transfusion strategy could be safe in children with hypoxemic respiratory failure.
However, it is important to highlight that 65 children screened for TRIPICU were excluded from the study because of hypoxemia, defined by Spo 2 less than 90% despite Fio 2 of at least 60%. Furthermore, seven children were temporarily suspended from the research protocol because of the occurrence of an "ARDS with overt systemic hypoxemia." The results of the TRIPICU study must thus be interpreted cautiously for children with respiratory failure and severe hypoxemia: no firm conclusion can be drawn from TRIPICU to guide RBC transfusions in these children.
Despite the lack of solid evidence to guide RBC transfusions in children with respiratory failure and hypoxemia, it must be emphasized that RBC transfusions have been shown to be associated with worsening of respiratory function, especially in critically ill children. For example, the incidence of transfusion-related ALI may be higher in children admitted to PICU than in the general pediatric population (23) . Furthermore, several observational studies have described an association between RBC transfusions and respiratory complications, even after adjustment for potential confounders in multivariable models: RBC transfusions have been found to be associated with worsening of oxygenation (24) (25) (26) , with increased duration of mechanical ventilation (5, 24-33), with an increased risk of respiratory dysfunction (1, 26) , and with an increased risk of ventilatory-associated pneumonia (34) . Obviously, these observational data do not permit establishment of a cause-effect relationship, but these reproducible findings must be kept in mind at the time of prescribing an RBC transfusion for a child with respiratory distress.
2.4
There is insufficient evidence to make a recommendation regarding transfusion thresholds for critically ill children with respiratory failure who have an Hb concentration between 5-7 g/dL. However, it is reasonable to consider transfusion based on clinical judgement in these children. Consensus panel expertise. Voting data (n = 35): 97% agreement, median 9, IQR 8-9.
Rationale. The Transfusion Requirements In Critical Care (TRICC) study showed that a restrictive transfusion strategy was safe in most critically ill adults. In this study, published 8 years before the TRIPICU study, the restrictive and the liberal thresholds (hemoglobin levels of 7 and 9 g/dL, respectively) were chosen based on stated transfusion practices in adult ICUs. Indeed, a survey conducted among 193 Canadian critical care physicians had shown that the baseline hemoglobin transfusion threshold averaged from 8.3 ± 1 to 9.5 ± 1 g/dL depending on the clinical scenario proposed (35) . The thresholds used in the TRICC study were subsequently retained based on these stated practices, so that critical care physicians would not be reluctant to participate in the study. The same methodology was used to select the hemoglobin thresholds for the TRIPICU study. Laverdière et al (36) assessed transfusion practices in Canadian and European PICUs using an international survey. In that survey, most of the participating PICU physicians responded that they would use a hemoglobin threshold of 7-10 g/dL to prescribe RBCs in critically ill children.
Thus, the restrictive thresholds used in both the adult and the pediatric RCT, which led to the current recommendations on RBC transfusions in critically ill patients, are based on stated practices at the time of the design of these studies. As described above, observational data indicate that severe anemia is associated with worse outcomes, and it is recommended that RBCs be administered when the hemoglobin level is below 5 g/dL. However, there are no data indicating that a hemoglobin threshold of 7 g/dL is safer than a threshold between 5 and 7 g/dL. Until more data are available, it is reasonable to use clinical judgment for children with a hemoglobin level in this "5-7 g/dL gray zone." 2.5 We cannot recommend a specific RBC transfusion decision-making strategy using physiologic based metrics and biomarkers in critically children with respiratory failure. Rationale. Assessment of the accuracy of Do 2 is important to guide decision-making with regard to RBC transfusion in the critically ill. Traditional ways to measure this have included measurement of lactate, central (or mixed) venous oxygen saturation, and global hemodynamic markers such as mean arterial pressure and cardiac index. More recently, focus has been placed on other methods to detect derangements in Do 2 and/or utilization that are noninvasive, reliable, and sensitive such as near-infrared spectroscopy to assess regional tissue oxygenation, as well as bedside ultrasound techniques to assess the macrovascular hemodynamic factors in Do 2 (37) . All these biomarkers and metrics, many of which are surrogate markers of oxygen metabolism, reveal information about Do 2 and consumption but cannot be used as therapeutic targets at the present time unless they are more robustly assessed and shown to have clinical applicability and to be of value in clinical decision-making with regard to RBC transfusion. To date, no study has demonstrated a clinical benefit of using transfusion strategies guided by physiologic markers in children (including children with respiratory failure). Rationale. Children with severe hypoxemia and/or hemodynamic instability obviously are at increased risk of inadequate Do 2 , and it has been shown that PICU physicians frequently use RBC transfusions in an effort to improve Do 2 (4) . However, several issues may impair the ability of stored RBCs to improve Do 2 to the cells. For example, the storage lesions affect membrane deformability and can cause compromised NO signaling leading to acute microvascular dysregulation (6, 38) . Furthermore, RBC transfusions may contribute to respiratory failure: new or progressive respiratory dysfunction may be observed after RBC transfusion (5), and a circulatory overload associated with transfusion may occur and worsen gas exchange (39) . It is thus of great importance to develop appropriate transfusion strategies for critically ill children with respiratory failure, particularly for those with severe hypoxemia or hemodynamic instability.
CONCLUSIONS
The evidence to guide RBC transfusions in critically ill children with respiratory failure is scarce to date, especially for children with hypoxemia and/or hemodynamic instability. Observational data indicate that respiratory distress worsens the prognosis of children with severe anemia. On the other hand, there are data showing that RBC transfusions may worsen respiratory failure. Determining appropriate transfusion strategies is thus of utmost importance for these children.
Based on the currently available evidence, we strongly recommend to transfuse RBCs to children with respiratory failure who have a hemoglobin less than 5 g/dL, and not to administer RBCs to nonseverely hypoxemic, noncyanotic, and hemodynamically stable children with respiratory failure who have a hemoglobin greater than or equal to 7 g/dL. Studies are urgently required to develop appropriate decision-making processes to guide RBC transfusions in children with respiratory failure, especially in children with severe hypoxemia and/ or hemodynamic instability. These processes should include an adequate hemoglobin threshold as well as physiologic markers aiming to assess the appropriateness of the balance between oxygen consumption and Do 2 .
